Compare MicroSectors FANG and Innovation 3X Leveraged ETN (FNGU) vs Hims and Hers Health Inc (HIMS) Price & Performance

FNGU (MicroSectors FANG+ 3X Leveraged ETN) trades at $32.45, down 3.71% today, reflecting the inherent volatility of leveraged products. Technical indicators show a bullish moving average trend but neutral oscillators, with RSI levels suggesting overbought conditions. Recent news highlights significant downside volatility, including a 16% single-session drop on June 5, 2026, underscoring the risks of 3x leverage on tech stocks.

The outlook for FNGU remains highly speculative, driven by Nasdaq-100 volatility rather than company fundamentals. Investment opportunities exist for aggressive traders betting on tech rallies, but risks include amplified losses during market downturns and structural decay from daily rebalancing. Caution is warranted given the product's design for short-term trading.

HIMS stock trades at $30.00, down 5.57% amid mixed Q2 2026 results. Revenue growth remains strong, with a 2026 outlook raised to $3.1B-$3.3B, but profitability is pressured by margin compression and a wider-than-expected quarterly loss. Technical indicators are neutral to bearish, with the price near key support at $30. Recent news highlights an FTC investigation and class-action lawsuits as headwinds.

The investment outlook is cautious. Growth prospects from subscriber gains and AI integration are offset by significant margin challenges and regulatory risks. Analyst consensus is a Hold with a $33.00 price target, suggesting limited near-term upside amid profitability concerns and negative free cash flow trends.